More evidence that Alzheimer's disease may be inherited from your mother

March, 2011

A new study adds to growing evidence that having a mother with Alzheimer's disease is a greater risk factor than if your father suffered the disease.

A two-year study involving 53 older adults (60+) has found that those with a mother who had Alzheimer's disease had significantly more brain atrophy than those with a father or no parent with Alzheimer's disease. More specifically, they had twice as much gray matter shrinkage, and about one and a half times more whole brain shrinkage per year.

This atrophy was particularly concentrated in the precuneus and parahippocampal gyrus. Those with the APOE4 gene also had more atrophy in the frontal cortex than those who didn’t carry the ‘Alzheimer’s gene’.

This adds to evidence indicating that maternal history is a far greater risk factor for Alzheimer’s than paternal history. Eleven participants reported having a mother with Alzheimer's disease, 10 had a father with Alzheimer's disease and 32 had no family history of the disease. It has been estimated that people who have first-degree relatives with Alzheimer's disease are four to 10 times more likely to develop the disease.

http://www.eurekalert.org/pub_releases/2011-02/aaon-met022211.php

Reference:

[2167] Honea, R. A., Swerdlow R. H., Vidoni E. D., & Burns J. M.
(2011). Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.
Neurology. 76(9), 822 - 829.

seniors

genes

Alzheimers

Related News

Learning Facebook may keep seniors sharp

Preliminary findings from a small study show that older adults (68-91), after learning to use Facebook, performed about 25% better on tasks designed to measure their ability to continuously monitor and to quickly add or delete the contents of their

Cognitive decline in old age related to poorer sleep

Recent research has suggested that sleep problems might be a risk factor in developing Alzheimer’s, and in mild cognitive impairment.

Early surgical menopause linked to faster cognitive decline

The issue of the effect of menopause on women’s cognition, and whether hormone therapy helps older women fight cognitive decline and dementia, has been a murky one. Increasing evidence suggests that the timing and type of therapy is critical.

Why learning gets harder as we get older

A new study adds more support to the idea that the increasing difficulty in learning new information and skills that most of us experience as we age is not down to any difficulty in acquiring new information, but rests on the interference from all the old information.

Hearing loss accelerates cognitive decline in older adults

I’ve written before about the gathering evidence that sensory impairment, visual impairment and hearing loss in particular, is a risk factor for age-related cognitive decline and dementia.

Intensive training helps seniors with long-term aphasia

Here’s an encouraging study for all those who think that, because of age or physical damage, they must resign themselves to whatever cognitive impairment or decline they have suffered.

Inhibitory control deficits common in those with MCI

Providing some support for the finding I recently reported — that problems with semantic knowledge in those with mild cognitive impairment (

Chewing ability linked to reduced dementia risk

Previous research has pointed to an association between not having teeth and a higher risk of cognitive decline and dementia. One reason might have to do with inflammation — inflammation is a well-established risk factor, and at least one study has linked gum disease to a higher dementia risk.

Ginkgo biloba doesn’t prevent Alzheimer’s

Sad to say, another large study has given the thumbs down to ginkgo biloba preventing Alzheimer’s disease.

Popular cognitive test for Alzheimer’s insufficiently sensitive

New research suggests that reliance on the standard test Alzheimer's Disease Assessment Scale—Cognitive Behavior Section (ADAS-Cog) to measure cognitive changes in Alzheimer’s patients is a bad idea. The test is the most widely used measure of cognitive performance in clinical trials.

Pages